June 13, 2026
View Full Paper2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Key Points
- Evaluate the efficacy and role of nonstatin therapies in lowering LDL-cholesterol levels for patients at risk of atherosclerotic cardiovascular disease.
- Consensus guidelines developed by experts in cardiovascular disease management.
- Evaluation of various nonstatin therapies and their impact on LDL-cholesterol levels.
- Recommendations based on clinical evidence and expert opinion.
- Nonstatin therapies are effective in reducing LDL-cholesterol levels in specific patient populations.
- Implementation of these therapies can enhance overall cardiovascular risk management strategies.
- Personalized treatment approaches are recommended to optimize LDL-cholesterol lowering.
Abstract
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.